Skip to main content
Top
Published in: Malaria Journal 1/2009

Open Access 01-12-2009 | Research

WISDOM-II: Screening against multiple targets implicated in malaria using computational grid infrastructures

Authors: Vinod Kasam, Jean Salzemann, Marli Botha, Ana Dacosta, Gianluca Degliesposti, Raul Isea, Doman Kim, Astrid Maass, Colin Kenyon, Giulio Rastelli, Martin Hofmann-Apitius, Vincent Breton

Published in: Malaria Journal | Issue 1/2009

Login to get access

Abstract

Background

Despite continuous efforts of the international community to reduce the impact of malaria on developing countries, no significant progress has been made in the recent years and the discovery of new drugs is more than ever needed. Out of the many proteins involved in the metabolic activities of the Plasmodium parasite, some are promising targets to carry out rational drug discovery.

Motivation

Recent years have witnessed the emergence of grids, which are highly distributed computing infrastructures particularly well fitted for embarrassingly parallel computations like docking. In 2005, a first attempt at using grids for large-scale virtual screening focused on plasmepsins and ended up in the identification of previously unknown scaffolds, which were confirmed in vitro to be active plasmepsin inhibitors. Following this success, a second deployment took place in the fall of 2006 focussing on one well known target, dihydrofolate reductase (DHFR), and on a new promising one, glutathione-S-transferase.

Methods

In silico drug design, especially vHTS is a widely and well-accepted technology in lead identification and lead optimization. This approach, therefore builds, upon the progress made in computational chemistry to achieve more accurate in silico docking and in information technology to design and operate large scale grid infrastructures.

Results

On the computational side, a sustained infrastructure has been developed: docking at large scale, using different strategies in result analysis, storing of the results on the fly into MySQL databases and application of molecular dynamics refinement are MM-PBSA and MM-GBSA rescoring. The modeling results obtained are very promising. Based on the modeling results, In vitro results are underway for all the targets against which screening is performed.

Conclusion

The current paper describes the rational drug discovery activity at large scale, especially molecular docking using FlexX software on computational grids in finding hits against three different targets (PfGST, PfDHFR, PvDHFR (wild type and mutant forms) implicated in malaria. Grid-enabled virtual screening approach is proposed to produce focus compound libraries for other biological targets relevant to fight the infectious diseases of the developing world.
Appendix
Available only for authorised users
Literature
3.
go back to reference Bleicher KH, Boehm HJ, Mueller K, Alanine AI: Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003, 2: 369-378.CrossRefPubMed Bleicher KH, Boehm HJ, Mueller K, Alanine AI: Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discov. 2003, 2: 369-378.CrossRefPubMed
4.
go back to reference Boehm HJ, Schneider G: Virtual screening for bioactive molecules. 2000, New York: John Wiley & Sons, IncCrossRef Boehm HJ, Schneider G: Virtual screening for bioactive molecules. 2000, New York: John Wiley & Sons, IncCrossRef
5.
go back to reference Spencer RW: High throughput virtual screening of historic collections on the file size, biological targets and file diversity. Biotechnol Bioeng. 1998, 61: 61-67.CrossRefPubMed Spencer RW: High throughput virtual screening of historic collections on the file size, biological targets and file diversity. Biotechnol Bioeng. 1998, 61: 61-67.CrossRefPubMed
6.
go back to reference Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The protein data bank. Nucleic Acids Res. 2000, 28: 235-242.PubMedCentralCrossRefPubMed Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The protein data bank. Nucleic Acids Res. 2000, 28: 235-242.PubMedCentralCrossRefPubMed
7.
go back to reference Hoeltje HD, Sippl W, Rognan D, Folkers G: Molecular Modeling, Basics Principles And Applications. 2003, New York: John Wiley & Sons, Inc Hoeltje HD, Sippl W, Rognan D, Folkers G: Molecular Modeling, Basics Principles And Applications. 2003, New York: John Wiley & Sons, Inc
8.
go back to reference Bajorath J: Integration of virtual and high-throughput screening. Nat Rev Drug Discov. 2002, 1: 882-894.CrossRefPubMed Bajorath J: Integration of virtual and high-throughput screening. Nat Rev Drug Discov. 2002, 1: 882-894.CrossRefPubMed
9.
go back to reference Buyya R, Branson K, Giddy J, Abramson D: The virtual laboratory. A toolset to enable distributed molecular modeling for drug design on the worldwide grid. Concurrency Computat Pract Exper. 2003, 15: 1-25.CrossRef Buyya R, Branson K, Giddy J, Abramson D: The virtual laboratory. A toolset to enable distributed molecular modeling for drug design on the worldwide grid. Concurrency Computat Pract Exper. 2003, 15: 1-25.CrossRef
10.
go back to reference Jacq N, Salzemann J, Legre' Y, Reichstadt M, Jacq F, Zimmermann M, Maass A, Sridhar M, Kasam V, Schwichtenberg H, Hofmann M, Breton V: Demonstration of in silico docking at a large scale on grid infrastructure. Stud Health Technol Inform. 2006, 120: 155-157.PubMed Jacq N, Salzemann J, Legre' Y, Reichstadt M, Jacq F, Zimmermann M, Maass A, Sridhar M, Kasam V, Schwichtenberg H, Hofmann M, Breton V: Demonstration of in silico docking at a large scale on grid infrastructure. Stud Health Technol Inform. 2006, 120: 155-157.PubMed
11.
go back to reference Foster I, Kesselman C: Computational Grids. The Grid: Blueprint for a New Computing Infrastructure. 1999, San Fransisco: Morgan Kaufmann Publishers Foster I, Kesselman C: Computational Grids. The Grid: Blueprint for a New Computing Infrastructure. 1999, San Fransisco: Morgan Kaufmann Publishers
20.
go back to reference Richards WG: Virtual screening grid computing: The screensaver project. Nat Rev Drug Discov. 2002, 1: 551-555.CrossRefPubMed Richards WG: Virtual screening grid computing: The screensaver project. Nat Rev Drug Discov. 2002, 1: 551-555.CrossRefPubMed
21.
go back to reference Jacq N, Salzemann J, Legré Y, Reichstadt M, Jacq F, Medernach E, Zimmermann M, Maaß A, Sridhar M, Vinod-Kusam K, Montagnat J, Schwichtenberg H, Hofmann M, Breton V: Grid enabled virtual screening against malaria. J Grid Comput. 2008, 1: 29-43.CrossRef Jacq N, Salzemann J, Legré Y, Reichstadt M, Jacq F, Medernach E, Zimmermann M, Maaß A, Sridhar M, Vinod-Kusam K, Montagnat J, Schwichtenberg H, Hofmann M, Breton V: Grid enabled virtual screening against malaria. J Grid Comput. 2008, 1: 29-43.CrossRef
22.
go back to reference Kasam V, Zimmermann M, Maaß A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann M: Design of plasmepsin inhibitors: A virtual high throughput screening approach on the EGEE grid. J Chem Inf Model. 2007, 47: 1818-1828.CrossRefPubMed Kasam V, Zimmermann M, Maaß A, Schwichtenberg H, Wolf A, Jacq N, Breton V, Hofmann M: Design of plasmepsin inhibitors: A virtual high throughput screening approach on the EGEE grid. J Chem Inf Model. 2007, 47: 1818-1828.CrossRefPubMed
23.
go back to reference Degliesposti G, Kasam V, Da Costa A, Kang HK, Kim DW, Breton V, Doman Kim D, Rastelli G: Design and discovery of novel plasmepsin inhibitors using an automated workflow on large scale grids. Chem Med Chem. Degliesposti G, Kasam V, Da Costa A, Kang HK, Kim DW, Breton V, Doman Kim D, Rastelli G: Design and discovery of novel plasmepsin inhibitors using an automated workflow on large scale grids. Chem Med Chem.
24.
go back to reference Kasam V, Salzemann J, Jacq N, Mass A, Breton V: Large scale deployment of molecular docking application on computational grid infrastructures for combating malaria. Proceedings of the Seventh IEEE International Symposium on Cluster Computing and the Grid: May 14–17 2007; Rio de Janeiro. 2007, IEEE Computer Society, 691-700.CrossRef Kasam V, Salzemann J, Jacq N, Mass A, Breton V: Large scale deployment of molecular docking application on computational grid infrastructures for combating malaria. Proceedings of the Seventh IEEE International Symposium on Cluster Computing and the Grid: May 14–17 2007; Rio de Janeiro. 2007, IEEE Computer Society, 691-700.CrossRef
26.
go back to reference Muller S: Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol. 2004, 53 (5): 1291-1305.CrossRefPubMed Muller S: Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol. 2004, 53 (5): 1291-1305.CrossRefPubMed
27.
go back to reference Becker K, Tilley L, Vennerstrom JL, Roberts D: Oxidative stress in malaria parasite-infected erythrocytes, host-parasite interactions. Int J Parasitol. 2004, 34: 163-189.CrossRefPubMed Becker K, Tilley L, Vennerstrom JL, Roberts D: Oxidative stress in malaria parasite-infected erythrocytes, host-parasite interactions. Int J Parasitol. 2004, 34: 163-189.CrossRefPubMed
28.
go back to reference Cardoso RFM, Daniels DS, Bruns CM, Tainer JA: Characterization of the electrophile binding site and substrate binding mode of 26 kDa glutathione S-transferase form Schistosoma japonicum. Proteins. 2003, 5: 137-146.CrossRef Cardoso RFM, Daniels DS, Bruns CM, Tainer JA: Characterization of the electrophile binding site and substrate binding mode of 26 kDa glutathione S-transferase form Schistosoma japonicum. Proteins. 2003, 5: 137-146.CrossRef
29.
go back to reference Sheenan D, Meade G, Foley VM, Dowd CA: Structure function and evolution of glutathione transferases, implication for classification of non-mammalian members of an ancient super family. Biochem J. 2001, 360: 1-16.CrossRef Sheenan D, Meade G, Foley VM, Dowd CA: Structure function and evolution of glutathione transferases, implication for classification of non-mammalian members of an ancient super family. Biochem J. 2001, 360: 1-16.CrossRef
30.
go back to reference Srivastva P, Puri SK, Kamboj KK, Pandey VC: Glutathione S-transferase activity in malaria parasites. Trop Med Int Health. 1999, 4: 251-254.CrossRef Srivastva P, Puri SK, Kamboj KK, Pandey VC: Glutathione S-transferase activity in malaria parasites. Trop Med Int Health. 1999, 4: 251-254.CrossRef
31.
go back to reference Dubois VL, Platel DF, Pauly G, Tribouley-Duret J: Plasmodium berghei, implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp Parasitol. 1995, 81 (1): 117-124.CrossRefPubMed Dubois VL, Platel DF, Pauly G, Tribouley-Duret J: Plasmodium berghei, implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp Parasitol. 1995, 81 (1): 117-124.CrossRefPubMed
32.
go back to reference Miller LH, Baruch LD, Marsh K, Doumbo OK: The pathogenic basis of malaria. Nature. 2002, 415: 673-679.CrossRefPubMed Miller LH, Baruch LD, Marsh K, Doumbo OK: The pathogenic basis of malaria. Nature. 2002, 415: 673-679.CrossRefPubMed
33.
go back to reference Fritz-Wolf K, Becker A, Rahlfs S, Harwalt P, Schirmer RH, Kansch W, Becker K: X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A. 2003, 100: 13821-13826.PubMedCentralCrossRefPubMed Fritz-Wolf K, Becker A, Rahlfs S, Harwalt P, Schirmer RH, Kansch W, Becker K: X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A. 2003, 100: 13821-13826.PubMedCentralCrossRefPubMed
34.
go back to reference Perbandt M, Burmeister C, Walter RD, Betzel C, Liebau E: Native and inhibited structure of a Mu class related glutathione S- transferase from Plasmodium falciparum. J Biol Chem. 2004, 279 (2): 1336-1342.CrossRefPubMed Perbandt M, Burmeister C, Walter RD, Betzel C, Liebau E: Native and inhibited structure of a Mu class related glutathione S- transferase from Plasmodium falciparum. J Biol Chem. 2004, 279 (2): 1336-1342.CrossRefPubMed
35.
go back to reference Koehler RT, Villar HO, Bauer KE, Higgins DL: Ligand based protein alignment and isozyme specificity of glutathione S-transferase inhibitors. Proteins. 1997, 28: 202-216.CrossRefPubMed Koehler RT, Villar HO, Bauer KE, Higgins DL: Ligand based protein alignment and isozyme specificity of glutathione S-transferase inhibitors. Proteins. 1997, 28: 202-216.CrossRefPubMed
36.
go back to reference Liebau E, Bergmann B, Campbell AM, Teesdale-Spittle P, Brophy PM, Luersen K, Walter RD: The glutathione S-transferase from Plasmodium falciparum. Mol Biochem Parasitol. 2002, 124: 85-90.CrossRefPubMed Liebau E, Bergmann B, Campbell AM, Teesdale-Spittle P, Brophy PM, Luersen K, Walter RD: The glutathione S-transferase from Plasmodium falciparum. Mol Biochem Parasitol. 2002, 124: 85-90.CrossRefPubMed
38.
go back to reference Ahlm C, Wistrom J, Carlsson H: Chloroquine-resistant Plasmodium vivax in Borneo. J Travel Med. 1996, 3: 124-CrossRefPubMed Ahlm C, Wistrom J, Carlsson H: Chloroquine-resistant Plasmodium vivax in Borneo. J Travel Med. 1996, 3: 124-CrossRefPubMed
39.
go back to reference Young MD, Burgess RW: Pyrimethamine resistance in Plasmodium vivax malaria. Bull World Health Organ. 1959, 20 (1): 27-36.PubMedCentralPubMed Young MD, Burgess RW: Pyrimethamine resistance in Plasmodium vivax malaria. Bull World Health Organ. 1959, 20 (1): 27-36.PubMedCentralPubMed
40.
go back to reference Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Sno G: Association of genetic mutations in Plasmodium vivax DHFR with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlatos. Antimicrob Agents Chemother. 2001, 45: 3122-3127.PubMedCentralCrossRefPubMed Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Sno G: Association of genetic mutations in Plasmodium vivax DHFR with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlatos. Antimicrob Agents Chemother. 2001, 45: 3122-3127.PubMedCentralCrossRefPubMed
41.
go back to reference Kongsaeree P, Khongsuk P, Leartsakulpanich U, Chitnumsub P, Tarnchompoo B, Walkinshaw MD, Yuthavong Y: Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance. Proc Natl Acad Sci USA. 2005, 102: 13046-13051.PubMedCentralCrossRefPubMed Kongsaeree P, Khongsuk P, Leartsakulpanich U, Chitnumsub P, Tarnchompoo B, Walkinshaw MD, Yuthavong Y: Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance. Proc Natl Acad Sci USA. 2005, 102: 13046-13051.PubMedCentralCrossRefPubMed
43.
go back to reference Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV: Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA. 1997, 94: 1124-1129.PubMedCentralCrossRefPubMed Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV: Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA. 1997, 94: 1124-1129.PubMedCentralCrossRefPubMed
44.
go back to reference Yuthavong Y: Basis for antifolate action and resistance in malaria. Microbes Infect. 2002, 4 (2): 175-182.CrossRefPubMed Yuthavong Y: Basis for antifolate action and resistance in malaria. Microbes Infect. 2002, 4 (2): 175-182.CrossRefPubMed
45.
go back to reference Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrel R, Lowe G, Thebtaranonth Y, Yuthavong Y: Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg Med Chem. 2000, 8: 1117-1128.CrossRefPubMed Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrel R, Lowe G, Thebtaranonth Y, Yuthavong Y: Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg Med Chem. 2000, 8: 1117-1128.CrossRefPubMed
46.
go back to reference Rastelli G, Pacchioni S, Sirawaraporn W, Sirawaraporn R, Parenti MD, Ferrari AM: Structure of Plasmodium vivax dihydrofolate reductase determined by homology modeling and molecular dynamics refinement. Bioorg Med Chem Lett. 2003, 13: 3257-3260.CrossRefPubMed Rastelli G, Pacchioni S, Sirawaraporn W, Sirawaraporn R, Parenti MD, Ferrari AM: Structure of Plasmodium vivax dihydrofolate reductase determined by homology modeling and molecular dynamics refinement. Bioorg Med Chem Lett. 2003, 13: 3257-3260.CrossRefPubMed
47.
go back to reference Yuvaniyama J, Chitnumsub P, Kamchonwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y: Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol. 2003, 10: 357-365.CrossRefPubMed Yuvaniyama J, Chitnumsub P, Kamchonwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y: Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol. 2003, 10: 357-365.CrossRefPubMed
49.
go back to reference Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods R: The amber biomolecular simulation programs. J Comput Chem. 2005, 26: 1668-1688.PubMedCentralCrossRefPubMed Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods R: The amber biomolecular simulation programs. J Comput Chem. 2005, 26: 1668-1688.PubMedCentralCrossRefPubMed
50.
go back to reference Jakalian A, Bush BL, Jack DB, Bayly CI: Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. J Comput Chem. 2000, 21: 132-146.CrossRef Jakalian A, Bush BL, Jack DB, Bayly CI: Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. J Comput Chem. 2000, 21: 132-146.CrossRef
51.
go back to reference Wang J, Wolf RM, Caldwell JW, Kollamn PA, Case DA: Development and testing of a general amber force field. J Comput Chem. 2004, 25: 1157-1174.CrossRefPubMed Wang J, Wolf RM, Caldwell JW, Kollamn PA, Case DA: Development and testing of a general amber force field. J Comput Chem. 2004, 25: 1157-1174.CrossRefPubMed
53.
54.
go back to reference Rarey M, Kramer B, Lengauer T, Klebe G: A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996, 261: 470-489.CrossRefPubMed Rarey M, Kramer B, Lengauer T, Klebe G: A fast flexible docking method using an incremental construction algorithm. J Mol Biol. 1996, 261: 470-489.CrossRefPubMed
56.
go back to reference Rarey M, Kramer B, Lengauer T: The particle concept: placing discrete water molecules during protein-ligand docking predictions. Proteins. 1999, 34 (1): 17-28.CrossRefPubMed Rarey M, Kramer B, Lengauer T: The particle concept: placing discrete water molecules during protein-ligand docking predictions. Proteins. 1999, 34 (1): 17-28.CrossRefPubMed
57.
go back to reference Ferrari AM, Degliesposti G, Sgobba M, Rastelli G: Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors. Bioorg Med Chem. 2007, 15: 7865-7877.CrossRefPubMed Ferrari AM, Degliesposti G, Sgobba M, Rastelli G: Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors. Bioorg Med Chem. 2007, 15: 7865-7877.CrossRefPubMed
58.
go back to reference Rastelli G, Degliesposti G, Del Rio A, Sgobba M: Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening. Chem Biol Drug Des. 2009, 73: 283-286.CrossRefPubMed Rastelli G, Degliesposti G, Del Rio A, Sgobba M: Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening. Chem Biol Drug Des. 2009, 73: 283-286.CrossRefPubMed
59.
go back to reference Srinivasan J, Thomas E, Cheatham I, Cieplak P, Kollman PA, Case DA: Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices. J Am Chem Soc. 1998, 120: 9401-9409.CrossRef Srinivasan J, Thomas E, Cheatham I, Cieplak P, Kollman PA, Case DA: Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices. J Am Chem Soc. 1998, 120: 9401-9409.CrossRef
60.
go back to reference Kollman PA, Massova , Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE: Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000, 33: 889-97.CrossRefPubMed Kollman PA, Massova , Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE: Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000, 33: 889-97.CrossRefPubMed
63.
go back to reference Barnard JM, Downs GM, Willett PJ: Chemical similarity searching. Chem Inf Comput Sci. 1998, 38: 983-996.CrossRef Barnard JM, Downs GM, Willett PJ: Chemical similarity searching. Chem Inf Comput Sci. 1998, 38: 983-996.CrossRef
Metadata
Title
WISDOM-II: Screening against multiple targets implicated in malaria using computational grid infrastructures
Authors
Vinod Kasam
Jean Salzemann
Marli Botha
Ana Dacosta
Gianluca Degliesposti
Raul Isea
Doman Kim
Astrid Maass
Colin Kenyon
Giulio Rastelli
Martin Hofmann-Apitius
Vincent Breton
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2009
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-8-88

Other articles of this Issue 1/2009

Malaria Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.